Novel motif:31
From FANTOM5_SSTAR
name: | motif31_AGNCGT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0040040 | thermosensory behavior | 3.339396e-16 |
GO:0016071 | mRNA metabolic process | 4.302680e-16 |
GO:0006974 | response to DNA damage stimulus | 3.426783e-12 |
GO:0006396 | RNA processing | 9.438426e-12 |
GO:0015696 | ammonium transport | 3.329867e-11 |
GO:0044265 | cellular macromolecule catabolic process | 4.254472e-11 |
GO:0019087 | transformation of host cell by virus | 4.381098e-11 |
GO:0000387 | spliceosomal snRNP assembly | 1.894983e-10 |
GO:0071156 | regulation of cell cycle arrest | 1.942817e-10 |
GO:0016032 | viral reproduction | 2.017263e-10 |
GO:0006406 | mRNA export from nucleus | 1.508777e-9 |
GO:0000075 | cell cycle checkpoint | 1.704683e-9 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 2.353740e-9 |
GO:0071460 | cellular response to cell-matrix adhesion | 2.750550e-9 |
GO:0009057 | macromolecule catabolic process | 3.037853e-9 |
GO:0006281 | DNA repair | 3.448002e-9 |
GO:0070159 | mitochondrial threonyl-tRNA aminoacylation | 4.911660e-9 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 5.442713e-9 |
GO:0032232 | negative regulation of actin filament bundle assembly | 5.624073e-9 |
GO:0019048 | virus-host interaction | 1.682162e-8 |
GO:0006402 | mRNA catabolic process | 1.861474e-8 |
GO:0006405 | RNA export from nucleus | 1.970535e-8 |
GO:0006397 | mRNA processing | 2.479914e-8 |
GO:0070079 | histone H4-R3 demethylation | 2.951380e-8 |
GO:0070078 | histone H3-R2 demethylation | 2.951380e-8 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 2.951380e-8 |
GO:0000216 | M/G1 transition of mitotic cell cycle | 3.827258e-8 |
GO:0033235 | positive regulation of protein sumoylation | 5.222657e-8 |
GO:0008334 | histone mRNA metabolic process | 8.073750e-8 |
GO:0031330 | negative regulation of cellular catabolic process | 8.572815e-8 |
GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 9.470691e-8 |
GO:0000375 | RNA splicing, via transesterification reactions | 1.492181e-7 |
GO:0006401 | RNA catabolic process | 1.732306e-7 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 2.440186e-7 |
GO:0006261 | DNA-dependent DNA replication | 2.986390e-7 |
GO:0045820 | negative regulation of glycolysis | 3.136996e-7 |
GO:0000084 | S phase of mitotic cell cycle | 3.470036e-7 |
GO:0051549 | positive regulation of keratinocyte migration | 3.515988e-7 |
GO:0008380 | RNA splicing | 3.726007e-7 |
GO:0051028 | mRNA transport | 3.900733e-7 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 4.119281e-7 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 4.210498e-7 |
GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 4.297259e-7 |
GO:0071870 | cellular response to catecholamine stimulus | 4.322705e-7 |
GO:0035307 | positive regulation of protein dephosphorylation | 4.468729e-7 |
GO:0010498 | proteasomal protein catabolic process | 4.572185e-7 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 4.666078e-7 |
GO:0035306 | positive regulation of dephosphorylation | 4.969819e-7 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 4.997112e-7 |
GO:0035304 | regulation of protein dephosphorylation | 5.453468e-7 |
GO:0010626 | negative regulation of Schwann cell proliferation | 5.549906e-7 |
GO:0006369 | termination of RNA polymerase II transcription | 6.179263e-7 |
GO:0033554 | cellular response to stress | 6.706064e-7 |
GO:0031064 | negative regulation of histone deacetylation | 6.971983e-7 |
GO:0031440 | regulation of mRNA 3'-end processing | 7.261938e-7 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.097278e-6 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 1.253773e-6 |
GO:0051320 | S phase | 1.382436e-6 |
GO:0014894 | response to denervation involved in regulation of muscle adaptation | 1.435102e-6 |
GO:0031124 | mRNA 3'-end processing | 1.596968e-6 |
GO:0006370 | mRNA capping | 1.605886e-6 |
GO:0090304 | nucleic acid metabolic process | 1.606984e-6 |
GO:0042851 | L-alanine metabolic process | 1.734268e-6 |
GO:0030903 | notochord development | 1.894964e-6 |
GO:0014898 | cardiac muscle hypertrophy in response to stress | 1.989440e-6 |
GO:0006348 | chromatin silencing at telomere | 2.209443e-6 |
GO:0010564 | regulation of cell cycle process | 2.215013e-6 |
GO:0042770 | signal transduction in response to DNA damage | 2.220848e-6 |
GO:0000093 | mitotic telophase | 2.428807e-6 |
GO:0010832 | negative regulation of myotube differentiation | 3.047788e-6 |
GO:0032007 | negative regulation of TOR signaling cascade | 3.505057e-6 |
GO:0033233 | regulation of protein sumoylation | 3.580453e-6 |
GO:0031570 | DNA integrity checkpoint | 3.631511e-6 |
GO:0000077 | DNA damage checkpoint | 3.650011e-6 |
GO:0051567 | histone H3-K9 methylation | 3.702793e-6 |
GO:0006308 | DNA catabolic process | 4.413160e-6 |
GO:0000073 | spindle pole body separation | 4.750553e-6 |
GO:0006984 | ER-nucleus signaling pathway | 5.033112e-6 |
GO:0006353 | transcription termination, DNA-dependent | 5.159788e-6 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 5.179907e-6 |
GO:0006302 | double-strand break repair | 5.373075e-6 |
GO:0060033 | anatomical structure regression | 5.444278e-6 |
GO:0001843 | neural tube closure | 5.604186e-6 |
GO:0034660 | ncRNA metabolic process | 6.123287e-6 |
GO:0006424 | glutamyl-tRNA aminoacylation | 6.209836e-6 |
GO:0071874 | cellular response to norepinephrine stimulus | 7.462810e-6 |
GO:0031123 | RNA 3'-end processing | 7.465531e-6 |
GO:0014020 | primary neural tube formation | 7.831994e-6 |
GO:0060606 | tube closure | 7.908265e-6 |
GO:0032006 | regulation of TOR signaling cascade | 8.137523e-6 |
GO:0051497 | negative regulation of stress fiber assembly | 8.200817e-6 |
GO:0042254 | ribosome biogenesis | 8.353402e-6 |
GO:0016072 | rRNA metabolic process | 9.172331e-6 |
GO:0032506 | cytokinetic process | 9.480577e-6 |
GO:0050434 | positive regulation of viral transcription | 9.701624e-6 |
GO:0032929 | negative regulation of superoxide anion generation | 1.143021e-5 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.153467e-5 |
GO:0035573 | N-terminal peptidyl-serine trimethylation | 1.166469e-5 |
GO:0035572 | N-terminal peptidyl-serine dimethylation | 1.166469e-5 |
GO:0018016 | N-terminal peptidyl-proline dimethylation | 1.166469e-5 |
GO:0018012 | N-terminal peptidyl-alanine trimethylation | 1.166469e-5 |
GO:0043585 | nose morphogenesis | 1.322630e-5 |
GO:0009452 | RNA capping | 1.340322e-5 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 1.359134e-5 |
GO:0019321 | pentose metabolic process | 1.413620e-5 |
GO:0009992 | cellular water homeostasis | 1.439231e-5 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 1.469147e-5 |
GO:0002149 | hypochlorous acid biosynthetic process | 1.539957e-5 |
GO:0022616 | DNA strand elongation | 1.811986e-5 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.819826e-5 |
GO:0006271 | DNA strand elongation involved in DNA replication | 1.863820e-5 |
GO:0030952 | establishment or maintenance of cytoskeleton polarity | 1.972574e-5 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 2.071698e-5 |
GO:0051301 | cell division | 2.261911e-5 |
GO:0051256 | spindle midzone assembly involved in mitosis | 2.285264e-5 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.302713e-5 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 2.320763e-5 |
GO:0021658 | rhombomere 3 morphogenesis | 2.551616e-5 |
GO:0030823 | regulation of cGMP metabolic process | 2.561989e-5 |
GO:0008633 | activation of pro-apoptotic gene products | 2.572087e-5 |
GO:0061013 | regulation of mRNA catabolic process | 2.732523e-5 |
GO:0021569 | rhombomere 3 development | 2.878374e-5 |
GO:0006168 | adenine salvage | 2.949449e-5 |
GO:0031365 | N-terminal protein amino acid modification | 3.001879e-5 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 3.064303e-5 |
GO:0050658 | RNA transport | 3.072086e-5 |
GO:0051340 | regulation of ligase activity | 3.315365e-5 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.413141e-5 |
GO:0051168 | nuclear export | 3.449356e-5 |
GO:0006919 | activation of caspase activity | 3.551876e-5 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 3.625799e-5 |
GO:0000089 | mitotic metaphase | 3.633489e-5 |
GO:0006414 | translational elongation | 3.765204e-5 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 4.284426e-5 |
GO:0032933 | SREBP-mediated signaling pathway | 4.308694e-5 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 4.441486e-5 |
GO:0033683 | nucleotide-excision repair, DNA incision | 4.579598e-5 |
GO:0044243 | multicellular organismal catabolic process | 4.685642e-5 |
GO:0022415 | viral reproductive process | 4.728555e-5 |
GO:0048193 | Golgi vesicle transport | 4.831904e-5 |
GO:0006498 | N-terminal protein lipidation | 4.964708e-5 |
GO:0050685 | positive regulation of mRNA processing | 5.169926e-5 |
GO:0010608 | posttranscriptional regulation of gene expression | 5.301580e-5 |
GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis | 5.466894e-5 |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage checkpoint | 5.473095e-5 |
GO:0030574 | collagen catabolic process | 6.295760e-5 |
GO:0043280 | positive regulation of caspase activity | 6.356746e-5 |
GO:0072331 | signal transduction by p53 class mediator | 6.435485e-5 |
GO:0060263 | regulation of respiratory burst | 6.685046e-5 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 6.766363e-5 |
GO:0072395 | signal transduction involved in cell cycle checkpoint | 6.826222e-5 |
GO:0010830 | regulation of myotube differentiation | 7.282265e-5 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 7.597335e-5 |
GO:0010952 | positive regulation of peptidase activity | 7.743769e-5 |
GO:0051351 | positive regulation of ligase activity | 7.770028e-5 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.807051e-5 |
GO:0051725 | protein de-ADP-ribosylation | 8.056638e-5 |
GO:0002679 | respiratory burst involved in defense response | 8.826841e-5 |
GO:0006103 | 2-oxoglutarate metabolic process | 8.854528e-5 |
GO:0007346 | regulation of mitotic cell cycle | 8.912417e-5 |
GO:0006417 | regulation of translation | 9.465688e-5 |
GO:0045945 | positive regulation of transcription from RNA polymerase III promoter | 9.599947e-5 |
GO:0019448 | L-cysteine catabolic process | 9.615159e-5 |
GO:0006364 | rRNA processing | 9.844228e-5 |
GO:0006684 | sphingomyelin metabolic process | 1.038132e-4 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 1.091671e-4 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.099087e-4 |
GO:0043543 | protein acylation | 1.100592e-4 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 1.117369e-4 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 1.129647e-4 |
GO:0006228 | UTP biosynthetic process | 1.144378e-4 |
GO:0006165 | nucleoside diphosphate phosphorylation | 1.144378e-4 |
GO:0006183 | GTP biosynthetic process | 1.144378e-4 |
GO:0044257 | cellular protein catabolic process | 1.153769e-4 |
GO:0016070 | RNA metabolic process | 1.233522e-4 |
GO:0006403 | RNA localization | 1.245452e-4 |
GO:0006139 | nucleobase-containing compound metabolic process | 1.299578e-4 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.319308e-4 |
GO:0006433 | prolyl-tRNA aminoacylation | 1.331508e-4 |
GO:0018027 | peptidyl-lysine dimethylation | 1.394001e-4 |
GO:0010633 | negative regulation of epithelial cell migration | 1.438640e-4 |
GO:0000712 | resolution of meiotic recombination intermediates | 1.456227e-4 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 1.492986e-4 |
GO:0006014 | D-ribose metabolic process | 1.542177e-4 |
GO:0007130 | synaptonemal complex assembly | 1.615638e-4 |
GO:0007256 | activation of JNKK activity | 1.615638e-4 |
GO:0043654 | recognition of apoptotic cell | 1.625471e-4 |
GO:0006427 | histidyl-tRNA aminoacylation | 1.672828e-4 |
GO:0034470 | ncRNA processing | 1.673309e-4 |
GO:0006241 | CTP biosynthetic process | 1.706762e-4 |
GO:0006739 | NADP metabolic process | 1.729842e-4 |
GO:0035849 | nephric duct elongation | 1.747194e-4 |
GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation | 1.747194e-4 |
GO:0035852 | horizontal cell localization | 1.747194e-4 |
GO:0035502 | metanephric ureteric bud development | 1.747194e-4 |
GO:0035846 | oviduct epithelium development | 1.747194e-4 |
GO:0035847 | uterine epithelium development | 1.747194e-4 |
GO:0000730 | DNA recombinase assembly | 1.811755e-4 |
GO:0007127 | meiosis I | 1.824648e-4 |
GO:0001839 | neural plate morphogenesis | 1.896898e-4 |
GO:0018205 | peptidyl-lysine modification | 1.917405e-4 |
GO:0072404 | signal transduction involved in G1/S transition checkpoint | 2.024183e-4 |
GO:0051290 | protein heterotetramerization | 2.106658e-4 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 2.143214e-4 |
GO:0006479 | protein methylation | 2.241140e-4 |
GO:0043174 | nucleoside salvage | 2.312929e-4 |
GO:0030037 | actin filament reorganization involved in cell cycle | 2.394975e-4 |
GO:0071158 | positive regulation of cell cycle arrest | 2.489927e-4 |
GO:0033238 | regulation of cellular amine metabolic process | 2.533771e-4 |
GO:0051255 | spindle midzone assembly | 2.547294e-4 |
GO:0031397 | negative regulation of protein ubiquitination | 2.551312e-4 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 2.837637e-4 |
GO:0071934 | thiamine transmembrane transport | 2.854070e-4 |
GO:0046491 | L-methylmalonyl-CoA metabolic process | 2.854070e-4 |
GO:0022613 | ribonucleoprotein complex biogenesis | 2.875817e-4 |
GO:0035105 | sterol regulatory element binding protein import into nucleus | 2.924091e-4 |
GO:0014888 | striated muscle adaptation | 2.938761e-4 |
GO:0030163 | protein catabolic process | 2.990114e-4 |
GO:0070193 | synaptonemal complex organization | 3.013769e-4 |
GO:0046588 | negative regulation of calcium-dependent cell-cell adhesion | 3.031601e-4 |
GO:0009235 | cobalamin metabolic process | 3.031601e-4 |
GO:0006446 | regulation of translational initiation | 3.152775e-4 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 3.155118e-4 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 3.196679e-4 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 3.237418e-4 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 3.326258e-4 |
GO:0060253 | negative regulation of glial cell proliferation | 3.391081e-4 |
GO:0015695 | organic cation transport | 3.437762e-4 |
GO:0035305 | negative regulation of dephosphorylation | 3.588139e-4 |
GO:0043094 | cellular metabolic compound salvage | 3.960777e-4 |
GO:0043249 | erythrocyte maturation | 4.012059e-4 |
GO:0000209 | protein polyubiquitination | 4.043916e-4 |
GO:0000920 | cytokinetic cell separation | 4.217564e-4 |
GO:0006695 | cholesterol biosynthetic process | 4.228224e-4 |
GO:0010821 | regulation of mitochondrion organization | 4.519898e-4 |
GO:0006884 | cell volume homeostasis | 4.530644e-4 |
GO:2001014 | regulation of skeletal muscle cell differentiation | 4.557480e-4 |
GO:0071034 | CUT catabolic process | 4.586237e-4 |
GO:0003108 | negative regulation of the force of heart contraction by chemical signal | 4.591298e-4 |
GO:0035284 | brain segmentation | 4.595691e-4 |
GO:0034641 | cellular nitrogen compound metabolic process | 4.719225e-4 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 4.729698e-4 |
GO:0000354 | cis assembly of pre-catalytic spliceosome | 5.014950e-4 |
GO:0070345 | negative regulation of fat cell proliferation | 5.048586e-4 |
GO:0048075 | positive regulation of eye pigmentation | 5.101687e-4 |
GO:0007109 | cytokinesis, completion of separation | 5.149019e-4 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 5.200531e-4 |
GO:0010544 | negative regulation of platelet activation | 5.246825e-4 |
GO:0045838 | positive regulation of membrane potential | 5.263486e-4 |
GO:0019323 | pentose catabolic process | 5.460692e-4 |
GO:0060178 | regulation of exocyst localization | 5.504922e-4 |
GO:0001928 | regulation of exocyst assembly | 5.504922e-4 |
GO:0034198 | cellular response to amino acid starvation | 5.695751e-4 |
GO:0071474 | cellular hyperosmotic response | 5.695751e-4 |
GO:0003300 | cardiac muscle hypertrophy | 5.881166e-4 |
GO:0010833 | telomere maintenance via telomere lengthening | 5.894496e-4 |
GO:0019941 | modification-dependent protein catabolic process | 5.912574e-4 |
GO:0006844 | acyl carnitine transport | 5.940450e-4 |
GO:0034968 | histone lysine methylation | 5.985637e-4 |
GO:0051148 | negative regulation of muscle cell differentiation | 6.024406e-4 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 6.063736e-4 |
GO:0006273 | lagging strand elongation | 6.113125e-4 |
GO:0034421 | post-translational protein acetylation | 6.171879e-4 |
GO:0045727 | positive regulation of translation | 6.248065e-4 |
GO:0051402 | neuron apoptosis | 6.357100e-4 |
GO:0010225 | response to UV-C | 6.515192e-4 |
GO:0035308 | negative regulation of protein dephosphorylation | 6.599409e-4 |
GO:0006521 | regulation of cellular amino acid metabolic process | 6.703485e-4 |
GO:0006903 | vesicle targeting | 7.022835e-4 |
GO:0051324 | prophase | 7.094860e-4 |
GO:0016075 | rRNA catabolic process | 7.268562e-4 |
GO:0071318 | cellular response to ATP | 7.336487e-4 |
GO:0030826 | regulation of cGMP biosynthetic process | 7.356055e-4 |
GO:0015931 | nucleobase-containing compound transport | 7.518350e-4 |
GO:0030262 | apoptotic nuclear change | 7.801449e-4 |
GO:0000723 | telomere maintenance | 7.899233e-4 |
GO:0010923 | negative regulation of phosphatase activity | 7.913186e-4 |
GO:0061014 | positive regulation of mRNA catabolic process | 7.957179e-4 |
GO:0001841 | neural tube formation | 8.055027e-4 |
GO:0035854 | eosinophil fate commitment | 8.341761e-4 |
GO:0090140 | regulation of mitochondrial fission | 8.341761e-4 |
GO:0030222 | eosinophil differentiation | 8.341761e-4 |
GO:0044003 | modification by symbiont of host morphology or physiology | 8.492769e-4 |
GO:0031577 | spindle checkpoint | 8.604689e-4 |
GO:0007093 | mitotic cell cycle checkpoint | 8.731420e-4 |
GO:0031120 | snRNA pseudouridine synthesis | 8.765500e-4 |
GO:0019303 | D-ribose catabolic process | 8.765500e-4 |
GO:0010677 | negative regulation of cellular carbohydrate metabolic process | 8.884082e-4 |
GO:0035461 | vitamin transmembrane transport | 9.061954e-4 |
GO:0043137 | DNA replication, removal of RNA primer | 9.205136e-4 |
GO:0006685 | sphingomyelin catabolic process | 9.278774e-4 |
GO:0043632 | modification-dependent macromolecule catabolic process | 9.317789e-4 |
GO:0006471 | protein ADP-ribosylation | 9.452019e-4 |
GO:0042796 | snRNA transcription from RNA polymerase III promoter | 9.523205e-4 |
GO:0051885 | positive regulation of anagen | 9.523205e-4 |
GO:0014835 | myoblast cell differentiation involved in skeletal muscle regeneration | 9.523205e-4 |
GO:0009234 | menaquinone biosynthetic process | 9.523205e-4 |
GO:0042795 | snRNA transcription from RNA polymerase II promoter | 9.523205e-4 |
GO:2000756 | regulation of peptidyl-lysine acetylation | 9.540411e-4 |
GO:0051129 | negative regulation of cellular component organization | 9.556681e-4 |
GO:0016570 | histone modification | 9.666938e-4 |
GO:0006499 | N-terminal protein myristoylation | 9.875423e-4 |
GO:0061302 | smooth muscle cell-matrix adhesion | 9.896975e-4 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 9.896975e-4 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 9.937534e-4 |
GO:0045647 | negative regulation of erythrocyte differentiation | 1.028158e-3 |
GO:0021568 | rhombomere 2 development | 1.046630e-3 |
GO:0033299 | secretion of lysosomal enzymes | 1.070955e-3 |
GO:0008053 | mitochondrial fusion | 1.087702e-3 |
GO:0051321 | meiotic cell cycle | 1.095957e-3 |
GO:0008630 | DNA damage response, signal transduction resulting in induction of apoptosis | 1.109693e-3 |
GO:0048205 | COPI coating of Golgi vesicle | 1.117776e-3 |
GO:0010822 | positive regulation of mitochondrion organization | 1.159816e-3 |
GO:0031648 | protein destabilization | 1.186332e-3 |
GO:0022011 | myelination in peripheral nervous system | 1.195937e-3 |
GO:0071843 | cellular component biogenesis at cellular level | 1.238368e-3 |
GO:0006740 | NADPH regeneration | 1.290212e-3 |
GO:0006188 | IMP biosynthetic process | 1.312590e-3 |
GO:0031297 | replication fork processing | 1.381421e-3 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 1.391026e-3 |
GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 1.406472e-3 |
GO:0007126 | meiosis | 1.410513e-3 |
GO:0006289 | nucleotide-excision repair | 1.426061e-3 |
GO:0042218 | 1-aminocyclopropane-1-carboxylate biosynthetic process | 1.476438e-3 |
GO:0045426 | quinone cofactor biosynthetic process | 1.478319e-3 |
GO:0006563 | L-serine metabolic process | 1.478319e-3 |
GO:0050783 | cocaine metabolic process | 1.481744e-3 |
GO:0000090 | mitotic anaphase | 1.485888e-3 |
GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 1.507581e-3 |
GO:0006312 | mitotic recombination | 1.551645e-3 |
GO:0006098 | pentose-phosphate shunt | 1.566413e-3 |
GO:0019083 | viral transcription | 1.618323e-3 |
GO:0070997 | neuron death | 1.636886e-3 |
GO:0090085 | regulation of protein deubiquitination | 1.645017e-3 |
GO:0016569 | covalent chromatin modification | 1.657668e-3 |
GO:0010543 | regulation of platelet activation | 1.666532e-3 |
GO:0006807 | nitrogen compound metabolic process | 1.678435e-3 |
GO:0043488 | regulation of mRNA stability | 1.703582e-3 |
GO:0061205 | paramesonephric duct development | 1.752895e-3 |
GO:0033577 | protein glycosylation in endoplasmic reticulum | 1.784295e-3 |
GO:0000088 | mitotic prophase | 1.784295e-3 |
GO:0030967 | ER-nuclear sterol response pathway | 1.789455e-3 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 1.794601e-3 |
GO:0097107 | postsynaptic density assembly | 1.794601e-3 |
GO:0070682 | proteasome regulatory particle assembly | 1.794601e-3 |
GO:0007141 | male meiosis I | 1.801349e-3 |
GO:0006398 | histone mRNA 3'-end processing | 1.870008e-3 |
GO:0006264 | mitochondrial DNA replication | 1.885979e-3 |
GO:0051322 | anaphase | 1.898777e-3 |
GO:0035356 | cellular triglyceride homeostasis | 1.924166e-3 |
GO:0032201 | telomere maintenance via semi-conservative replication | 1.950263e-3 |
GO:0051568 | histone H3-K4 methylation | 1.966294e-3 |
GO:0014044 | Schwann cell development | 1.966294e-3 |
GO:0070192 | chromosome organization involved in meiosis | 1.968225e-3 |
GO:0032200 | telomere organization | 1.975907e-3 |
GO:0007129 | synapsis | 2.047134e-3 |
GO:0006287 | base-excision repair, gap-filling | 2.059609e-3 |
GO:0050779 | RNA destabilization | 2.059984e-3 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 2.078733e-3 |
GO:0090307 | spindle assembly involved in mitosis | 2.123521e-3 |
GO:0031055 | chromatin remodeling at centromere | 2.133914e-3 |
GO:0009744 | response to sucrose stimulus | 2.195439e-3 |
GO:0008535 | respiratory chain complex IV assembly | 2.198005e-3 |
GO:0006413 | translational initiation | 2.207352e-3 |
GO:0045556 | positive regulation of TRAIL biosynthetic process | 2.208963e-3 |
GO:0002921 | negative regulation of humoral immune response | 2.209047e-3 |
GO:0046782 | regulation of viral transcription | 2.249084e-3 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 2.259359e-3 |
GO:0030825 | positive regulation of cGMP metabolic process | 2.261733e-3 |
GO:0032042 | mitochondrial DNA metabolic process | 2.266354e-3 |
GO:0046108 | uridine metabolic process | 2.290232e-3 |
GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion | 2.324073e-3 |
GO:0014806 | smooth muscle hyperplasia | 2.367752e-3 |
GO:0006473 | protein acetylation | 2.383633e-3 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 2.406748e-3 |
GO:0010639 | negative regulation of organelle organization | 2.429066e-3 |
GO:0042699 | follicle-stimulating hormone signaling pathway | 2.465552e-3 |
GO:0031575 | mitotic cell cycle G1/S transition checkpoint | 2.530739e-3 |
GO:0070179 | D-serine biosynthetic process | 2.561924e-3 |
GO:0008049 | male courtship behavior | 2.561924e-3 |
GO:0006713 | glucocorticoid catabolic process | 2.561924e-3 |
GO:0050684 | regulation of mRNA processing | 2.583554e-3 |
GO:0051650 | establishment of vesicle localization | 2.641534e-3 |
GO:0090199 | regulation of release of cytochrome c from mitochondria | 2.647859e-3 |
GO:0018209 | peptidyl-serine modification | 2.671578e-3 |
GO:0042727 | flavin-containing compound biosynthetic process | 2.677891e-3 |
GO:0002268 | follicular dendritic cell differentiation | 2.682996e-3 |
GO:0001840 | neural plate development | 2.743654e-3 |
GO:0046365 | monosaccharide catabolic process | 2.761534e-3 |
GO:0016197 | endosome transport | 2.763385e-3 |
GO:0060136 | embryonic process involved in female pregnancy | 2.768348e-3 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 2.768557e-3 |
GO:0007128 | meiotic prophase I | 2.777095e-3 |
GO:0030422 | production of siRNA involved in RNA interference | 2.783399e-3 |
GO:0050774 | negative regulation of dendrite morphogenesis | 2.783399e-3 |
GO:0070814 | hydrogen sulfide biosynthetic process | 2.810131e-3 |
GO:0043096 | purine base salvage | 2.872784e-3 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 2.884765e-3 |
GO:0006354 | transcription elongation, DNA-dependent | 2.898087e-3 |
GO:0043153 | entrainment of circadian clock by photoperiod | 2.924192e-3 |
GO:0045065 | cytotoxic T cell differentiation | 3.007528e-3 |
GO:0043973 | histone H3-K4 acetylation | 3.038710e-3 |
GO:0045090 | retroviral genome replication | 3.038710e-3 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 3.038710e-3 |
GO:0043418 | homocysteine catabolic process | 3.038710e-3 |
GO:0019346 | transsulfuration | 3.038710e-3 |
GO:0006535 | cysteine biosynthetic process from serine | 3.038710e-3 |
GO:0019343 | cysteine biosynthetic process via cystathionine | 3.038710e-3 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 3.038710e-3 |
GO:0090234 | regulation of kinetochore assembly | 3.043264e-3 |
GO:0090169 | regulation of spindle assembly | 3.043264e-3 |
GO:0090009 | primitive streak formation | 3.069587e-3 |
GO:0006476 | protein deacetylation | 3.112300e-3 |
GO:0014896 | muscle hypertrophy | 3.124169e-3 |
GO:0014805 | smooth muscle adaptation | 3.190058e-3 |
GO:0043487 | regulation of RNA stability | 3.216508e-3 |
GO:0022004 | midbrain-hindbrain boundary maturation during brain development | 3.225551e-3 |
GO:2000002 | negative regulation of DNA damage checkpoint | 3.225551e-3 |
GO:0021588 | cerebellum formation | 3.225551e-3 |
GO:0021551 | central nervous system morphogenesis | 3.225551e-3 |
GO:0071779 | G1/S transition checkpoint | 3.255376e-3 |
GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation | 3.280894e-3 |
GO:0048194 | Golgi vesicle budding | 3.292252e-3 |
GO:0008272 | sulfate transport | 3.292252e-3 |
GO:0035065 | regulation of histone acetylation | 3.343462e-3 |
GO:0048873 | homeostasis of number of cells within a tissue | 3.359899e-3 |
GO:0044275 | cellular carbohydrate catabolic process | 3.372818e-3 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 3.381907e-3 |
GO:0016571 | histone methylation | 3.404498e-3 |
GO:0006986 | response to unfolded protein | 3.494954e-3 |
GO:0016926 | protein desumoylation | 3.526169e-3 |
GO:0009070 | serine family amino acid biosynthetic process | 3.607531e-3 |
GO:0045652 | regulation of megakaryocyte differentiation | 3.689571e-3 |
GO:0009303 | rRNA transcription | 3.707552e-3 |
GO:0046543 | development of secondary female sexual characteristics | 3.767469e-3 |
GO:0006972 | hyperosmotic response | 3.767469e-3 |
GO:0006707 | cholesterol catabolic process | 3.772444e-3 |
GO:0035303 | regulation of dephosphorylation | 3.773027e-3 |
GO:0006892 | post-Golgi vesicle-mediated transport | 3.776781e-3 |
GO:0034389 | lipid particle organization | 3.819527e-3 |
GO:0021759 | globus pallidus development | 3.869661e-3 |
GO:0048808 | male genitalia morphogenesis | 3.882097e-3 |
GO:0016255 | attachment of GPI anchor to protein | 3.882097e-3 |
GO:0071173 | spindle assembly checkpoint | 3.910636e-3 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 3.926664e-3 |
GO:0048073 | regulation of eye pigmentation | 3.996954e-3 |
GO:0006043 | glucosamine catabolic process | 4.092471e-3 |
GO:0035883 | enteroendocrine cell differentiation | 4.115746e-3 |
GO:0051926 | negative regulation of calcium ion transport | 4.194286e-3 |
GO:0042538 | hyperosmotic salinity response | 4.298993e-3 |
GO:0032259 | methylation | 4.315110e-3 |
GO:0009650 | UV protection | 4.339527e-3 |
GO:0071872 | cellular response to epinephrine stimulus | 4.413918e-3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 4.413918e-3 |
GO:0060179 | male mating behavior | 4.413918e-3 |
GO:0042696 | menarche | 4.692390e-3 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 4.709878e-3 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 4.740291e-3 |
GO:0018993 | somatic sex determination | 4.763153e-3 |
GO:0035601 | protein deacylation | 4.840519e-3 |
GO:0090141 | positive regulation of mitochondrial fission | 4.855876e-3 |
GO:0006166 | purine ribonucleoside salvage | 4.855876e-3 |
GO:0000917 | barrier septum formation | 4.861970e-3 |
GO:0015788 | UDP-N-acetylglucosamine transport | 4.861970e-3 |
GO:0071044 | histone mRNA catabolic process | 4.910527e-3 |
GO:0007283 | spermatogenesis | 4.996967e-3 |
GO:0030799 | regulation of cyclic nucleotide metabolic process | 5.120398e-3 |
GO:0051383 | kinetochore organization | 5.207193e-3 |
GO:0006998 | nuclear envelope organization | 5.239586e-3 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 5.247000e-3 |
GO:0035036 | sperm-egg recognition | 5.319014e-3 |
GO:0006457 | protein folding | 5.323931e-3 |
GO:0046939 | nucleotide phosphorylation | 5.360510e-3 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 5.448342e-3 |
GO:0071233 | cellular response to leucine | 5.550832e-3 |
GO:0043097 | pyrimidine nucleoside salvage | 5.552385e-3 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 5.568279e-3 |
GO:0007208 | activation of phospholipase C activity by serotonin receptor signaling pathway | 5.572091e-3 |
GO:0051323 | metaphase | 5.610933e-3 |
GO:0007181 | transforming growth factor beta receptor complex assembly | 5.677049e-3 |
GO:0000722 | telomere maintenance via recombination | 5.757068e-3 |
GO:0007049 | cell cycle | 5.823047e-3 |
GO:0048291 | isotype switching to IgG isotypes | 5.841721e-3 |
GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint | 5.841721e-3 |
GO:0018364 | peptidyl-glutamine methylation | 5.841721e-3 |
GO:0071423 | malate transmembrane transport | 5.841721e-3 |
GO:0009436 | glyoxylate catabolic process | 5.841721e-3 |
GO:0002368 | B cell cytokine production | 5.841721e-3 |
GO:0015709 | thiosulfate transport | 5.841721e-3 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 5.841721e-3 |
GO:0006430 | lysyl-tRNA aminoacylation | 5.841721e-3 |
GO:0006913 | nucleocytoplasmic transport | 5.901138e-3 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 5.941548e-3 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 5.948497e-3 |
GO:0009301 | snRNA transcription | 5.948497e-3 |
GO:0018345 | protein palmitoylation | 6.001496e-3 |
GO:0021528 | commissural neuron differentiation in spinal cord | 6.044351e-3 |
GO:0060464 | lung lobe formation | 6.091247e-3 |
GO:0060379 | cardiac muscle cell myoblast differentiation | 6.091247e-3 |
GO:0060520 | activation of prostate induction by androgen receptor signaling pathway | 6.091247e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0090304 | nucleic acid metabolic process | 8.176212e-11 |
GO:0034660 | ncRNA metabolic process | 1.420171e-10 |
GO:0000279 | M phase | 1.456276e-10 |
GO:0051026 | chiasma assembly | 1.977223e-10 |
GO:0090086 | negative regulation of protein deubiquitination | 2.515037e-10 |
GO:0090084 | negative regulation of inclusion body assembly | 7.340749e-10 |
GO:0010467 | gene expression | 1.095555e-9 |
GO:0007126 | meiosis | 1.270672e-9 |
GO:0051321 | meiotic cell cycle | 3.280890e-9 |
GO:0016070 | RNA metabolic process | 6.702323e-9 |
GO:0044260 | cellular macromolecule metabolic process | 1.017788e-8 |
GO:0034470 | ncRNA processing | 1.375506e-8 |
GO:0007131 | reciprocal meiotic recombination | 2.757125e-8 |
GO:0016557 | peroxisome membrane biogenesis | 7.563259e-8 |
GO:0048280 | vesicle fusion with Golgi apparatus | 7.565630e-8 |
GO:0044265 | cellular macromolecule catabolic process | 8.128503e-8 |
GO:0006139 | nucleobase-containing compound metabolic process | 8.548175e-8 |
GO:0043570 | maintenance of DNA repeat elements | 1.101708e-7 |
GO:0022403 | cell cycle phase | 1.711197e-7 |
GO:0043488 | regulation of mRNA stability | 1.827262e-7 |
GO:0030163 | protein catabolic process | 2.691330e-7 |
GO:0007127 | meiosis I | 3.456155e-7 |
GO:0043487 | regulation of RNA stability | 4.703215e-7 |
GO:0010312 | detoxification of zinc ion | 4.970101e-7 |
GO:0033205 | cell cycle cytokinesis | 5.750732e-7 |
GO:0048255 | mRNA stabilization | 7.172062e-7 |
GO:0070842 | aggresome assembly | 7.203121e-7 |
GO:0006412 | translation | 7.336361e-7 |
GO:0032715 | negative regulation of interleukin-6 production | 7.596206e-7 |
GO:0006399 | tRNA metabolic process | 9.629454e-7 |
GO:0044257 | cellular protein catabolic process | 9.977388e-7 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 1.020069e-6 |
GO:0014826 | vein smooth muscle contraction | 1.034461e-6 |
GO:0022402 | cell cycle process | 1.071891e-6 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 1.078579e-6 |
GO:0051865 | protein autoubiquitination | 1.084488e-6 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 1.117068e-6 |
GO:0006396 | RNA processing | 1.146084e-6 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 1.196665e-6 |
GO:0009057 | macromolecule catabolic process | 1.282411e-6 |
GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 1.420802e-6 |
GO:0007497 | posterior midgut development | 1.517861e-6 |
GO:0035645 | enteric smooth muscle cell differentiation | 1.517861e-6 |
GO:0051148 | negative regulation of muscle cell differentiation | 1.929469e-6 |
GO:0006540 | glutamate decarboxylation to succinate | 2.138978e-6 |
GO:0008033 | tRNA processing | 2.167295e-6 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 2.462092e-6 |
GO:0016559 | peroxisome fission | 2.688941e-6 |
GO:0031577 | spindle checkpoint | 2.776909e-6 |
GO:0061181 | regulation of chondrocyte development | 3.024510e-6 |
GO:0003166 | bundle of His development | 3.037080e-6 |
GO:0090085 | regulation of protein deubiquitination | 3.154212e-6 |
GO:0010159 | specification of organ position | 3.458164e-6 |
GO:0033083 | regulation of immature T cell proliferation | 4.271490e-6 |
GO:0034641 | cellular nitrogen compound metabolic process | 5.259140e-6 |
GO:0070192 | chromosome organization involved in meiosis | 5.872505e-6 |
GO:0007129 | synapsis | 6.179931e-6 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 6.663133e-6 |
GO:0032720 | negative regulation of tumor necrosis factor production | 6.982864e-6 |
GO:0046112 | nucleobase biosynthetic process | 7.222726e-6 |
GO:0006281 | DNA repair | 7.680531e-6 |
GO:0051276 | chromosome organization | 7.876224e-6 |
GO:0035990 | tendon cell differentiation | 8.304269e-6 |
GO:0016926 | protein desumoylation | 9.119533e-6 |
GO:0006298 | mismatch repair | 9.358809e-6 |
GO:0006105 | succinate metabolic process | 9.358809e-6 |
GO:0080111 | DNA demethylation | 1.006067e-5 |
GO:0002268 | follicular dendritic cell differentiation | 1.123399e-5 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.154355e-5 |
GO:0000724 | double-strand break repair via homologous recombination | 1.327909e-5 |
GO:0072192 | ureter epithelial cell differentiation | 1.441106e-5 |
GO:0072198 | mesenchymal cell proliferation involved in ureter development | 1.441106e-5 |
GO:0072101 | specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway | 1.441106e-5 |
GO:0072200 | negative regulation of mesenchymal cell proliferation involved in ureter development | 1.441106e-5 |
GO:0090194 | negative regulation of glomerulus development | 1.441106e-5 |
GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis | 1.441106e-5 |
GO:2000007 | negative regulation of metanephric comma-shaped body morphogenesis | 1.441106e-5 |
GO:2000005 | negative regulation of metanephric S-shaped body morphogenesis | 1.441106e-5 |
GO:0072097 | negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway | 1.441106e-5 |
GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis | 1.441106e-5 |
GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development | 1.441106e-5 |
GO:0055020 | positive regulation of cardiac muscle fiber development | 1.441106e-5 |
GO:0048627 | myoblast development | 1.441106e-5 |
GO:0071893 | BMP signaling pathway involved in nephric duct formation | 1.441106e-5 |
GO:0007500 | mesodermal cell fate determination | 1.441106e-5 |
GO:0060502 | epithelial cell proliferation involved in lung morphogenesis | 1.441106e-5 |
GO:0048392 | intermediate mesodermal cell differentiation | 1.441106e-5 |
GO:0061155 | pulmonary artery endothelial tube morphogenesis | 1.441106e-5 |
GO:0060503 | bud dilation involved in lung branching | 1.441106e-5 |
GO:0061151 | BMP signaling pathway involved in renal system segmentation | 1.441106e-5 |
GO:0061149 | BMP signaling pathway involved in ureter morphogenesis | 1.441106e-5 |
GO:0071173 | spindle assembly checkpoint | 1.483078e-5 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 1.499289e-5 |
GO:0061037 | negative regulation of cartilage development | 1.514103e-5 |
GO:0006457 | protein folding | 1.541930e-5 |
GO:0010614 | negative regulation of cardiac muscle hypertrophy | 1.660148e-5 |
GO:0000281 | cytokinesis after mitosis | 1.726641e-5 |
GO:0006545 | glycine biosynthetic process | 1.755220e-5 |
GO:0043170 | macromolecule metabolic process | 1.821659e-5 |
GO:0032423 | regulation of mismatch repair | 2.063290e-5 |
GO:0006310 | DNA recombination | 2.115257e-5 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 2.149278e-5 |
GO:0072361 | regulation of glycolysis by regulation of transcription from RNA polymerase II promoter | 2.149278e-5 |
GO:0006446 | regulation of translational initiation | 2.307719e-5 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 2.321821e-5 |
GO:0034645 | cellular macromolecule biosynthetic process | 2.356256e-5 |
GO:0051983 | regulation of chromosome segregation | 2.569389e-5 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 2.669919e-5 |
GO:0060299 | negative regulation of sarcomere organization | 2.669919e-5 |
GO:0009059 | macromolecule biosynthetic process | 3.002081e-5 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 3.072275e-5 |
GO:0000725 | recombinational repair | 3.472372e-5 |
GO:0045839 | negative regulation of mitosis | 3.503103e-5 |
GO:0021999 | neural plate anterior/posterior regionalization | 3.858663e-5 |
GO:0014043 | negative regulation of neuron maturation | 3.858663e-5 |
GO:0006538 | glutamate catabolic process | 3.858663e-5 |
GO:0019941 | modification-dependent protein catabolic process | 3.984639e-5 |
GO:0043632 | modification-dependent macromolecule catabolic process | 4.071549e-5 |
GO:0006259 | DNA metabolic process | 4.111561e-5 |
GO:0032057 | negative regulation of translational initiation in response to stress | 4.136427e-5 |
GO:0008616 | queuosine biosynthetic process | 4.136427e-5 |
GO:0007049 | cell cycle | 4.207789e-5 |
GO:0045143 | homologous chromosome segregation | 4.490368e-5 |
GO:0061088 | regulation of sequestering of zinc ion | 6.171368e-5 |
GO:0061302 | smooth muscle cell-matrix adhesion | 6.705732e-5 |
GO:0032717 | negative regulation of interleukin-8 production | 6.771928e-5 |
GO:0060684 | epithelial-mesenchymal cell signaling | 7.023470e-5 |
GO:0016574 | histone ubiquitination | 7.311592e-5 |
GO:0031507 | heterochromatin formation | 8.023088e-5 |
GO:0045662 | negative regulation of myoblast differentiation | 8.107215e-5 |
GO:0048599 | oocyte development | 8.789306e-5 |
GO:0031109 | microtubule polymerization or depolymerization | 9.014856e-5 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 9.063696e-5 |
GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 9.233702e-5 |
GO:0010933 | positive regulation of macrophage tolerance induction | 1.024453e-4 |
GO:0048285 | organelle fission | 1.087086e-4 |
GO:0016071 | mRNA metabolic process | 1.103610e-4 |
GO:0048246 | macrophage chemotaxis | 1.104989e-4 |
GO:0021547 | midbrain-hindbrain boundary initiation | 1.140143e-4 |
GO:0021501 | prechordal plate formation | 1.140143e-4 |
GO:0006419 | alanyl-tRNA aminoacylation | 1.140143e-4 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 1.166199e-4 |
GO:0070534 | protein K63-linked ubiquitination | 1.196115e-4 |
GO:0006448 | regulation of translational elongation | 1.347073e-4 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 1.373505e-4 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.373505e-4 |
GO:0046452 | dihydrofolate metabolic process | 1.373505e-4 |
GO:0032707 | negative regulation of interleukin-23 production | 1.373505e-4 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 1.373505e-4 |
GO:0045362 | positive regulation of interleukin-1 biosynthetic process | 1.373505e-4 |
GO:0006513 | protein monoubiquitination | 1.378663e-4 |
GO:0019047 | provirus integration | 1.388495e-4 |
GO:0032383 | regulation of intracellular cholesterol transport | 1.388495e-4 |
GO:0006094 | gluconeogenesis | 1.396442e-4 |
GO:0014741 | negative regulation of muscle hypertrophy | 1.463819e-4 |
GO:0042254 | ribosome biogenesis | 1.491807e-4 |
GO:0050774 | negative regulation of dendrite morphogenesis | 1.590378e-4 |
GO:0009452 | RNA capping | 1.590378e-4 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.656556e-4 |
GO:0051725 | protein de-ADP-ribosylation | 1.711862e-4 |
GO:0090083 | regulation of inclusion body assembly | 1.717848e-4 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.881432e-4 |
GO:0034661 | ncRNA catabolic process | 1.916456e-4 |
GO:0035306 | positive regulation of dephosphorylation | 2.005630e-4 |
GO:0051261 | protein depolymerization | 2.010637e-4 |
GO:0019319 | hexose biosynthetic process | 2.080273e-4 |
GO:0071877 | regulation of adrenergic receptor signaling pathway | 2.088790e-4 |
GO:0007019 | microtubule depolymerization | 2.088790e-4 |
GO:0043502 | regulation of muscle adaptation | 2.092815e-4 |
GO:0009106 | lipoate metabolic process | 2.112410e-4 |
GO:0045792 | negative regulation of cell size | 2.188481e-4 |
GO:0070602 | regulation of centromeric sister chromatid cohesion | 2.227366e-4 |
GO:0000087 | M phase of mitotic cell cycle | 2.313735e-4 |
GO:0045947 | negative regulation of translational initiation | 2.369732e-4 |
GO:0009994 | oocyte differentiation | 2.470466e-4 |
GO:0060010 | Sertoli cell fate commitment | 2.685298e-4 |
GO:0006807 | nitrogen compound metabolic process | 2.755095e-4 |
GO:0060591 | chondroblast differentiation | 2.784526e-4 |
GO:0006304 | DNA modification | 2.814281e-4 |
GO:0010564 | regulation of cell cycle process | 2.850617e-4 |
GO:0006499 | N-terminal protein myristoylation | 2.913162e-4 |
GO:0060319 | primitive erythrocyte differentiation | 2.974291e-4 |
GO:0007067 | mitosis | 3.008182e-4 |
GO:0070244 | negative regulation of thymocyte apoptosis | 3.108273e-4 |
GO:0035510 | DNA dealkylation | 3.552112e-4 |
GO:0001881 | receptor recycling | 3.580324e-4 |
GO:0002537 | nitric oxide production involved in inflammatory response | 3.789013e-4 |
GO:0051445 | regulation of meiotic cell cycle | 4.056368e-4 |
GO:0072362 | regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter | 4.057320e-4 |
GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter | 4.057320e-4 |
GO:0010832 | negative regulation of myotube differentiation | 4.114673e-4 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 4.116864e-4 |
GO:0032446 | protein modification by small protein conjugation | 4.250738e-4 |
GO:0090042 | tubulin deacetylation | 4.753005e-4 |
GO:0070846 | Hsp90 deacetylation | 4.753005e-4 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 4.753005e-4 |
GO:0070086 | ubiquitin-dependent endocytosis | 4.753005e-4 |
GO:0021591 | ventricular system development | 4.798019e-4 |
GO:0042306 | regulation of protein import into nucleus | 4.819114e-4 |
GO:0010388 | cullin deneddylation | 4.863165e-4 |
GO:2000744 | positive regulation of anterior head development | 4.939784e-4 |
GO:0071218 | cellular response to misfolded protein | 4.969970e-4 |
GO:0060948 | cardiac vascular smooth muscle cell development | 4.969970e-4 |
GO:0055025 | positive regulation of cardiac muscle tissue development | 4.969970e-4 |
GO:0003161 | cardiac conduction system development | 5.023809e-4 |
GO:0014829 | vascular smooth muscle contraction | 5.105796e-4 |
GO:0010498 | proteasomal protein catabolic process | 5.327428e-4 |
GO:0010611 | regulation of cardiac muscle hypertrophy | 5.335235e-4 |
GO:0051964 | negative regulation of synapse assembly | 5.361267e-4 |
GO:0035993 | deltoid tuberosity development | 5.669509e-4 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 5.817156e-4 |
GO:0003130 | BMP signaling pathway involved in heart induction | 5.817156e-4 |
GO:0031047 | gene silencing by RNA | 5.934337e-4 |
GO:0007059 | chromosome segregation | 6.075884e-4 |
GO:0070918 | production of small RNA involved in gene silencing by RNA | 6.117580e-4 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 6.197505e-4 |
GO:0045908 | negative regulation of vasodilation | 6.208695e-4 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 6.208695e-4 |
GO:0009435 | NAD biosynthetic process | 6.649863e-4 |
GO:0010830 | regulation of myotube differentiation | 6.668406e-4 |
GO:0040020 | regulation of meiosis | 6.752864e-4 |
GO:0031396 | regulation of protein ubiquitination | 6.795469e-4 |
GO:0045132 | meiotic chromosome segregation | 6.934111e-4 |
GO:0006351 | transcription, DNA-dependent | 6.960901e-4 |
GO:0007088 | regulation of mitosis | 7.046246e-4 |
GO:0046491 | L-methylmalonyl-CoA metabolic process | 7.081420e-4 |
GO:0016078 | tRNA catabolic process | 7.081420e-4 |
GO:0001682 | tRNA 5'-leader removal | 7.081420e-4 |
GO:0032774 | RNA biosynthetic process | 7.188211e-4 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 7.294526e-4 |
GO:0034122 | negative regulation of toll-like receptor signaling pathway | 7.301656e-4 |
GO:0043973 | histone H3-K4 acetylation | 7.329666e-4 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 7.329666e-4 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 7.329666e-4 |
GO:0044249 | cellular biosynthetic process | 7.362741e-4 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 7.368372e-4 |
GO:0035196 | production of miRNAs involved in gene silencing by miRNA | 7.472134e-4 |
GO:0071359 | cellular response to dsRNA | 7.517386e-4 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 7.529645e-4 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 7.529645e-4 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 7.529645e-4 |
GO:0016191 | synaptic vesicle uncoating | 7.529645e-4 |
GO:0001829 | trophectodermal cell differentiation | 7.586094e-4 |
GO:0043331 | response to dsRNA | 8.019370e-4 |
GO:0051932 | synaptic transmission, GABAergic | 8.133939e-4 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 8.137015e-4 |
GO:0051961 | negative regulation of nervous system development | 8.619724e-4 |
GO:0032119 | sequestering of zinc ion | 8.958571e-4 |
GO:0033235 | positive regulation of protein sumoylation | 9.005084e-4 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 9.016766e-4 |
GO:0060449 | bud elongation involved in lung branching | 9.020080e-4 |
GO:0030218 | erythrocyte differentiation | 9.040639e-4 |
GO:0060932 | His-Purkinje system cell differentiation | 9.070203e-4 |
GO:0060926 | pacemaker cell development | 9.070203e-4 |
GO:0034637 | cellular carbohydrate biosynthetic process | 9.199503e-4 |
GO:0021670 | lateral ventricle development | 9.437866e-4 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 9.948497e-4 |
GO:0044267 | cellular protein metabolic process | 1.017184e-3 |
GO:0042274 | ribosomal small subunit biogenesis | 1.028571e-3 |
GO:0035511 | oxidative DNA demethylation | 1.086874e-3 |
GO:0046477 | glycosylceramide catabolic process | 1.086874e-3 |
GO:0001886 | endothelial cell morphogenesis | 1.089579e-3 |
GO:0035117 | embryonic arm morphogenesis | 1.110061e-3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 1.116479e-3 |
GO:0060686 | negative regulation of prostatic bud formation | 1.118263e-3 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 1.139166e-3 |
GO:0070432 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.148305e-3 |
GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 1.148305e-3 |
GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 1.148305e-3 |
GO:0006405 | RNA export from nucleus | 1.166252e-3 |
GO:0006264 | mitochondrial DNA replication | 1.167572e-3 |
GO:0016540 | protein autoprocessing | 1.176111e-3 |
GO:0016598 | protein arginylation | 1.221011e-3 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 1.237959e-3 |
GO:0071477 | cellular hypotonic salinity response | 1.246717e-3 |
GO:0048384 | retinoic acid receptor signaling pathway | 1.278470e-3 |
GO:0034587 | piRNA metabolic process | 1.284683e-3 |
GO:0014743 | regulation of muscle hypertrophy | 1.327824e-3 |
GO:0043330 | response to exogenous dsRNA | 1.367288e-3 |
GO:0033572 | transferrin transport | 1.374777e-3 |
GO:0008215 | spermine metabolic process | 1.379336e-3 |
GO:0000395 | nuclear mRNA 5'-splice site recognition | 1.379336e-3 |
GO:0071843 | cellular component biogenesis at cellular level | 1.390126e-3 |
GO:0046587 | positive regulation of calcium-dependent cell-cell adhesion | 1.401385e-3 |
GO:0043148 | mitotic spindle stabilization | 1.401385e-3 |
GO:0006713 | glucocorticoid catabolic process | 1.401385e-3 |
GO:0019264 | glycine biosynthetic process from serine | 1.401385e-3 |
GO:0032606 | type I interferon production | 1.402562e-3 |
GO:0051099 | positive regulation of binding | 1.414546e-3 |
GO:0090244 | Wnt receptor signaling pathway involved in somitogenesis | 1.512223e-3 |
GO:0048570 | notochord morphogenesis | 1.517858e-3 |
GO:0070989 | oxidative demethylation | 1.526336e-3 |
GO:0016567 | protein ubiquitination | 1.542324e-3 |
GO:0061047 | positive regulation of branching involved in lung morphogenesis | 1.613980e-3 |
GO:0061154 | endothelial tube morphogenesis | 1.613980e-3 |
GO:0001825 | blastocyst formation | 1.640189e-3 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 1.666170e-3 |
GO:0045083 | negative regulation of interleukin-12 biosynthetic process | 1.682892e-3 |
GO:0003416 | endochondral bone growth | 1.701328e-3 |
GO:0014041 | regulation of neuron maturation | 1.746284e-3 |
GO:0071322 | cellular response to carbohydrate stimulus | 1.751198e-3 |
GO:0001678 | cellular glucose homeostasis | 1.782983e-3 |
GO:0034983 | peptidyl-lysine deacetylation | 1.784310e-3 |
GO:0010936 | negative regulation of macrophage cytokine production | 1.784310e-3 |
GO:0002832 | negative regulation of response to biotic stimulus | 1.907517e-3 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 1.930433e-3 |
GO:0061312 | BMP signaling pathway involved in heart development | 1.959801e-3 |
GO:0032859 | activation of Ral GTPase activity | 1.959801e-3 |
GO:0002701 | negative regulation of production of molecular mediator of immune response | 1.973466e-3 |
GO:0090224 | regulation of spindle organization | 1.973636e-3 |
GO:2000054 | negative regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.982688e-3 |
GO:0033091 | positive regulation of immature T cell proliferation | 1.982688e-3 |
GO:0051984 | positive regulation of chromosome segregation | 2.015334e-3 |
GO:0006420 | arginyl-tRNA aminoacylation | 2.015334e-3 |
GO:0008617 | guanosine metabolic process | 2.015334e-3 |
GO:0006323 | DNA packaging | 2.036399e-3 |
GO:0060136 | embryonic process involved in female pregnancy | 2.051006e-3 |
GO:0034101 | erythrocyte homeostasis | 2.115148e-3 |
GO:0006427 | histidyl-tRNA aminoacylation | 2.131373e-3 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 2.131373e-3 |
GO:0001309 | age-dependent telomere shortening | 2.131373e-3 |
GO:0000209 | protein polyubiquitination | 2.170135e-3 |
GO:0001824 | blastocyst development | 2.187763e-3 |
GO:0018193 | peptidyl-amino acid modification | 2.233224e-3 |
GO:0006403 | RNA localization | 2.264059e-3 |
GO:0042694 | muscle cell fate specification | 2.280187e-3 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 2.297232e-3 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 2.315711e-3 |
GO:0051030 | snRNA transport | 2.343821e-3 |
GO:0019509 | L-methionine salvage from methylthioadenosine | 2.343821e-3 |
GO:0046364 | monosaccharide biosynthetic process | 2.350695e-3 |
GO:0060897 | neural plate regionalization | 2.368408e-3 |
GO:0007619 | courtship behavior | 2.368408e-3 |
GO:0007256 | activation of JNKK activity | 2.458391e-3 |
GO:0006913 | nucleocytoplasmic transport | 2.469729e-3 |
GO:0045668 | negative regulation of osteoblast differentiation | 2.477798e-3 |
GO:0006325 | chromatin organization | 2.499787e-3 |
GO:0051238 | sequestering of metal ion | 2.541395e-3 |
GO:0044091 | membrane biogenesis | 2.541395e-3 |
GO:0021903 | rostrocaudal neural tube patterning | 2.543248e-3 |
GO:0018205 | peptidyl-lysine modification | 2.543917e-3 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 2.559460e-3 |
GO:0001710 | mesodermal cell fate commitment | 2.559460e-3 |
GO:0003167 | atrioventricular bundle cell differentiation | 2.569251e-3 |
GO:0060931 | sinoatrial node cell development | 2.569251e-3 |
GO:0071879 | positive regulation of adrenergic receptor signaling pathway | 2.615553e-3 |
GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development | 2.615553e-3 |
GO:0045924 | regulation of female receptivity | 2.651117e-3 |
GO:0007130 | synaptonemal complex assembly | 2.731645e-3 |
GO:0051351 | positive regulation of ligase activity | 2.746362e-3 |
GO:0044237 | cellular metabolic process | 2.794364e-3 |
GO:0070193 | synaptonemal complex organization | 2.798395e-3 |
GO:0003214 | cardiac left ventricle morphogenesis | 2.815542e-3 |
GO:0008380 | RNA splicing | 2.845794e-3 |
GO:0048389 | intermediate mesoderm development | 2.905521e-3 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 2.905521e-3 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 2.905521e-3 |
GO:0006398 | histone mRNA 3'-end processing | 2.905521e-3 |
GO:0007031 | peroxisome organization | 2.965219e-3 |
GO:0030261 | chromosome condensation | 3.019603e-3 |
GO:0016568 | chromatin modification | 3.042324e-3 |
GO:0042136 | neurotransmitter biosynthetic process | 3.082796e-3 |
GO:0010519 | negative regulation of phospholipase activity | 3.118791e-3 |
GO:0006189 | 'de novo' IMP biosynthetic process | 3.118791e-3 |
GO:0035552 | oxidative single-stranded DNA demethylation | 3.154501e-3 |
GO:0043154 | negative regulation of caspase activity | 3.193340e-3 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 3.196617e-3 |
GO:0021592 | fourth ventricle development | 3.200475e-3 |
GO:0070498 | interleukin-1-mediated signaling pathway | 3.204752e-3 |
GO:0001556 | oocyte maturation | 3.216659e-3 |
GO:0010935 | regulation of macrophage cytokine production | 3.246756e-3 |
GO:0045820 | negative regulation of glycolysis | 3.355927e-3 |
GO:0032007 | negative regulation of TOR signaling cascade | 3.438705e-3 |
GO:0050691 | regulation of defense response to virus by host | 3.456718e-3 |
GO:0046822 | regulation of nucleocytoplasmic transport | 3.474798e-3 |
GO:0071624 | positive regulation of granulocyte chemotaxis | 3.517568e-3 |
GO:0051684 | maintenance of Golgi location | 3.517568e-3 |
GO:0017126 | nucleologenesis | 3.517568e-3 |
GO:0060920 | pacemaker cell differentiation | 3.641156e-3 |
GO:0021539 | subthalamus development | 3.775692e-3 |
GO:0007063 | regulation of sister chromatid cohesion | 4.114603e-3 |
GO:0055118 | negative regulation of cardiac muscle contraction | 4.175879e-3 |
GO:0060466 | activation of meiosis involved in egg activation | 4.175879e-3 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 4.175879e-3 |
GO:0007259 | JAK-STAT cascade | 4.208464e-3 |
GO:0032232 | negative regulation of actin filament bundle assembly | 4.242726e-3 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 4.298935e-3 |
GO:0051096 | positive regulation of helicase activity | 4.371455e-3 |
GO:0061156 | pulmonary artery morphogenesis | 4.371455e-3 |
GO:0046755 | non-lytic virus budding | 4.435602e-3 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 4.435602e-3 |
GO:0008208 | C21-steroid hormone catabolic process | 4.435602e-3 |
GO:0006930 | substrate-dependent cell migration, cell extension | 4.435602e-3 |
GO:0050658 | RNA transport | 4.567870e-3 |
GO:0009798 | axis specification | 4.622799e-3 |
GO:0090128 | regulation of synapse maturation | 4.624720e-3 |
GO:0021532 | neural tube patterning | 4.644797e-3 |
GO:0071394 | cellular response to testosterone stimulus | 4.647372e-3 |
GO:0006450 | regulation of translational fidelity | 4.647372e-3 |
GO:0060032 | notochord regression | 4.647372e-3 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 4.735969e-3 |
GO:0045948 | positive regulation of translational initiation | 4.735969e-3 |
GO:0042376 | phylloquinone catabolic process | 4.816741e-3 |
GO:0060699 | regulation of endoribonuclease activity | 4.816741e-3 |
GO:0032802 | low-density lipoprotein particle receptor catabolic process | 4.816741e-3 |
GO:0070370 | cellular heat acclimation | 4.816741e-3 |
GO:0000055 | ribosomal large subunit export from nucleus | 4.816741e-3 |
GO:0000056 | ribosomal small subunit export from nucleus | 4.816741e-3 |
GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.816741e-3 |
GO:0071375 | cellular response to peptide hormone stimulus | 4.854025e-3 |
GO:0031120 | snRNA pseudouridine synthesis | 4.891495e-3 |
GO:0034048 | negative regulation of protein phosphatase type 2A activity | 4.933693e-3 |
GO:0009450 | gamma-aminobutyric acid catabolic process | 4.933693e-3 |
GO:0006349 | regulation of gene expression by genetic imprinting | 5.098016e-3 |
GO:0002030 | inhibitory G-protein coupled receptor phosphorylation | 5.224768e-3 |
GO:0033233 | regulation of protein sumoylation | 5.237172e-3 |
GO:0031573 | intra-S DNA damage checkpoint | 5.243634e-3 |
GO:0021678 | third ventricle development | 5.243634e-3 |
GO:0051169 | nuclear transport | 5.325979e-3 |
GO:0009058 | biosynthetic process | 5.343541e-3 |
GO:0016569 | covalent chromatin modification | 5.384485e-3 |
GO:0015931 | nucleobase-containing compound transport | 5.413059e-3 |
GO:0030952 | establishment or maintenance of cytoskeleton polarity | 5.457058e-3 |
GO:0032239 | regulation of nucleobase-containing compound transport | 5.559844e-3 |
GO:0007172 | signal complex assembly | 5.559844e-3 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 5.614290e-3 |
GO:0018208 | peptidyl-proline modification | 5.616703e-3 |
GO:0045596 | negative regulation of cell differentiation | 5.696623e-3 |
GO:0043543 | protein acylation | 5.704227e-3 |
GO:0030903 | notochord development | 5.706261e-3 |
GO:0046655 | folic acid metabolic process | 5.707507e-3 |
GO:0060312 | regulation of blood vessel remodeling | 5.715401e-3 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 5.782270e-3 |
GO:0071034 | CUT catabolic process | 5.798872e-3 |
GO:0031508 | centromeric heterochromatin formation | 5.798872e-3 |
GO:0061311 | cell surface receptor linked signaling pathway involved in heart development | 6.032527e-3 |
GO:0000045 | autophagic vacuole assembly | 6.112119e-3 |
GO:0003417 | growth plate cartilage development | 6.142575e-3 |
GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway | 6.167196e-3 |
GO:0000070 | mitotic sister chromatid segregation | 6.192495e-3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 6.408044e-3 |
GO:0046479 | glycosphingolipid catabolic process | 6.522668e-3 |
GO:0003222 | ventricular trabecular myocardium morphogenesis | 6.522668e-3 |
GO:0006119 | oxidative phosphorylation | 6.665817e-3 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 6.699705e-3 |
GO:0000715 | nucleotide-excision repair, DNA damage recognition | 6.699705e-3 |
GO:0048002 | antigen processing and presentation of peptide antigen | 6.713219e-3 |
GO:0032754 | positive regulation of interleukin-5 production | 6.742145e-3 |
GO:0016570 | histone modification | 6.915609e-3 |
GO:0060438 | trachea development | 7.007948e-3 |
GO:0046532 | regulation of photoreceptor cell differentiation | 7.019521e-3 |
GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly | 7.044586e-3 |
GO:0060363 | cranial suture morphogenesis | 7.107786e-3 |
GO:0045836 | positive regulation of meiosis | 7.107786e-3 |
GO:0045585 | positive regulation of cytotoxic T cell differentiation | 7.113825e-3 |
GO:0034421 | post-translational protein acetylation | 7.113825e-3 |
GO:0006120 | mitochondrial electron transport, NADH to ubiquinone | 7.113825e-3 |
GO:0009107 | lipoate biosynthetic process | 7.113825e-3 |
GO:0043558 | regulation of translational initiation in response to stress | 7.222375e-3 |
GO:0040029 | regulation of gene expression, epigenetic | 7.307435e-3 |
GO:0016072 | rRNA metabolic process | 7.345341e-3 |
GO:0060911 | cardiac cell fate commitment | 7.392831e-3 |
GO:0018195 | peptidyl-arginine modification | 7.392831e-3 |
GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway | 7.392831e-3 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 7.400723e-3 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 7.458593e-3 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 7.458593e-3 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 7.458593e-3 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 7.458593e-3 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 7.486140e-3 |
GO:0051150 | regulation of smooth muscle cell differentiation | 7.607238e-3 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 7.689799e-3 |
GO:0021680 | cerebellar Purkinje cell layer development | 7.689799e-3 |
GO:0070925 | organelle assembly | 7.803385e-3 |
GO:0007281 | germ cell development | 7.933752e-3 |
GO:0071333 | cellular response to glucose stimulus | 8.069196e-3 |
GO:0016202 | regulation of striated muscle tissue development | 8.194770e-3 |
GO:0006397 | mRNA processing | 8.341736e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 8.466001e-3 |
GO:0050916 | sensory perception of sweet taste | 8.466001e-3 |
GO:0006408 | snRNA export from nucleus | 8.466001e-3 |
GO:0002071 | glandular epithelial cell maturation | 8.466001e-3 |
GO:0045624 | positive regulation of T-helper cell differentiation | 8.498984e-3 |
GO:0097084 | vascular smooth muscle cell development | 8.516777e-3 |
GO:0043248 | proteasome assembly | 8.516777e-3 |
GO:0060318 | definitive erythrocyte differentiation | 8.516777e-3 |
GO:0003218 | cardiac left ventricle formation | 8.523924e-3 |
GO:0046092 | deoxycytidine metabolic process | 8.550536e-3 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 8.550536e-3 |
GO:0032608 | interferon-beta production | 8.550536e-3 |
GO:0030433 | ER-associated protein catabolic process | 8.561163e-3 |
GO:0048634 | regulation of muscle organ development | 8.706056e-3 |
GO:0009451 | RNA modification | 8.811720e-3 |
GO:0034103 | regulation of tissue remodeling | 8.941199e-3 |
GO:0046599 | regulation of centriole replication | 8.975922e-3 |
GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation | 8.975922e-3 |
GO:0051068 | dihydrolipoamide metabolic process | 9.136419e-3 |
GO:0045872 | positive regulation of rhodopsin gene expression | 9.136419e-3 |
GO:0009438 | methylglyoxal metabolic process | 9.136419e-3 |
GO:0034205 | beta-amyloid formation | 9.136419e-3 |